Original Post: Marijuana Moment: Postal Service Unveils ‘Drug Free USA Forever’ Stamp Commemorating 1980s Anti-Drug Program
[Canniseur: I used to collect stamps. My dad taught me when I was a kid. I’m glad I sold my collection years ago. This is so wrong-headed that it defies belief. The post office has always been a bit retro, but in 2019, this is a poorly thought out decision, IMHO. Interestingly, the post office has released stamps recently gloriying the 1960s and its sex, drigs and rock and roll mantra.]
The U.S. Postal Service (USPS) is rolling out a new stamp design that pays tribute to 1980s-era drug prevention programs and promotes a “drug-free USA.”
The stamps, which will go on sale starting in October 2020, were announced at the conclusion of this year’s Red Ribbon Week last month, an annual occurrence first launched under the Reagan administration.
“This Drug Free USA Forever stamp will help further raise awareness about the dangers of drug abuse, and the toll it is taking on families and communities around our country,” Robert Duncan, chairman of the USPS Board of Governors, said in a press release. “The Postal Service is glad to do its part in marking Red Ribbon Week, and renewing our commitment to helping these efforts to educate youth about the dangers of illegal drugs.”
USPS explained that Red Ribbon Week originated after a Drug Enforcement Administration (DEA) agent was tortured and killed in Mexico while investigating drug traffickers in 1985.
“I am very pleased that the U.S. Postal Service will issue a stamp affirming our commitment to a drug-free America,” DEA Acting Administrator Uttam Dhillon said. “This stamp will help raise awareness of the fight against drug addiction and honor those who have dedicated their lives to that cause.”
A description of the design states that the stamp “features a white star with lines of red, light blue and blue radiating from one side of each of the star’s five points, suggesting the unity necessary at all levels to effectively address drug abuse.”
USPS isn’t applying anti-drug messaging to the cannabis component CBD anymore, however. In September, the agency clarified that hemp-derived CBD products can be mailed under certain circumstances since the crop and its derivatives were federally legalized under the 2018 Farm Bill.
For those with mailing needs who aren’t interested in supporting the notion of a “Drug Free USA,” USPS does have another stamp that recognizes the 50-year anniversary of the drug-fueled 1969 counterculture music festival Woodstock.
The stamp “features an image of a dove along with the words ‘3 DAYS OF PEACE AND MUSIC,’ evoking the original promotional poster for the festival,” USPS says.
Another option is a John Lennon Forever stamp, celebrating the iconic Beatles member and marijuana enthusiast who famously got “high with a little help” from his friends.
“Still beloved around the world, Lennon’s music remains an anchor of pop radio and continues to speak for truth and peace,” USPS wrote.
Top CDC Official Suggests Legal Marijuana Regulations Can Mitigate Vaping Injuries
Photo courtesy of Wikicommons.
The post Postal Service Unveils ‘Drug Free USA Forever’ Stamp Commemorating 1980s Anti-Drug Program appeared first on Marijuana Moment.
Postal Service Unveils ‘Drug Free USA Forever’ Stamp Commemorating 1980s Anti-Drug Program was posted on Marijuana Moment.
Original Post: Marijuana Moment: New Mexico Committee Gets Head Start On Marijuana Legalization For 2020 Session
[Canniseur: New Mexico rocks!!! I already knew that, but as the state legislature moves forward to create a legal adult-use cannabis market, it seems like they’re serious about making it happen. Certainly, the tax revenue won’t hurt the state at all. Will it keep people from driving to Colorado to purchase their cannabis? Who knows. A lot will depend on the tax structure and the quality of New Mexico weed.]
New Mexico lawmakers discussed the potential economic impact of legalizing marijuana in the state during a committee hearing on Wednesday.
The meeting of the legislature’s interim Economic and Rural Development Committee, which featured testimony from the chair of a governor-appointed cannabis working group, focused on issues such as a tax scheme for legal marijuana sales and the allocation of the resulting revenue.
While Pat Davis, the working group chair, touted the economic potential of the industry, he also recognized that “getting a business in marijuana is expensive—it costs about half a million to $1 million to open.” Given that, he said it was important to use revenue from cannabis sales to start a venture capital fund that could provide low-interest loans to disadvantaged communities to launch marijuana operations.
The committee convened one month after the Cannabis Working Group, formed by Gov. Michelle Lujan Grisham (D), released recommendations for a legal marijuana market. The governor aims to have a reform plan in place for the short 30-day legislative session starting in January 2020, meaning that New Mexico is positioned to potentially become the next state in the U.S. to legalize.
The working group’s report said New Mexico would gain 11,000 jobs and sales would reach $620 million annually within five years of implementation. Combined tax revenue from adult-use and medical cannabis sales would earn the state $100 million a year, they estimated.
Other recommendations included ensuring that prior marijuana convictions are expunged and prohibiting or restricting home cultivation.
Davis, who also serves as a member of the Albuquerque City Council, touched on a variety of these recommendations and emphasized that the working group wanted to incorporate law enforcement into conversations about legalization as legislative efforts move forward. He also said that marijuana would be “larger than most agricultural industries” once it’s legal in the state.
“New Mexico is ready for this,” he said. “We found that New Mexico has been doing this for 10 years already [with medical cannabis], and this is just a multiplier in terms of regulation and infrastructure. This is a real opportunity.”
Lawmakers also heard from Public Safety Department Secretary Mark Shea and University of New Mexico economics professor Sarah Stith.
Shea discussed the need to fund efforts to train officers as drug recognition experts and said agencies are looking forward to having field testing options to detect impaired driving.
In March, the House approved a bill that would legalize marijuana and provide for sales to be conducted primarily through state-run stores. A Senate committee advanced that bill, but it later stalled before reaching a floor vote in the chamber. The Cannabis Working Group said in September that it opposed a government-run marijuana model.
Senate President Mary Kay Papen (D) said this week that she is “not really enthusiastic” about legalization legislation but remains open to the possibility, the Associated Press reported.
Also this year, the legislature passed a bill decriminalizing cannabis possession, which was signed into law by the governor in April and officially took effect on July 1.
Photo courtesy of Mike Latimer.
New Mexico Committee Gets Head Start On Marijuana Legalization For 2020 Session was posted on Marijuana Moment.
Original Post: Marijuana Moment: Senate Approves Bill Protecting Medical Marijuana States From Federal Intervention
[Canniseur: The Senate passing anything that protects states from the wrath of the feds is almost a miracle in itself. This bill doesn’t quite go far enough, but it’s a start. It does not cover adult use cannabis states. And it doesn’t include the banking provisions so dispensaries don’t have to deal only with cash like the old dope dealer days, which is the situation they’re currently in.]
The Senate approved spending legislation on Thursday that extends a provision protecting medical marijuana states from federal interference—but the question remains as to whether a House-passed version with broader protections for all state cannabis programs could still be adopted in the final bill that’s sent to the president.
The so-called “minibus” appropriations legislation covers funding for Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation and Housing and Urban Development for the 2020 fiscal year.
The vote on the bill, which also includes new hemp and CBD-related language, was 84 to 9.
The medical cannabis provision in question prohibits the Department of Justice from using its resources to prosecute individuals acting in compliance with state laws. The rider has been in place and renewed each year since 2014.
But after the House passed a Justice Department spending bill in June that for the first time would extend those protections to all state cannabis programs, including those allowing recreational use and sales, some advocates hoped the Senate would follow suit. In the lead up to a committee markup where that would have happened, however, several senators told Marijuana Moment that the prospects were unlikely, as congressional leaders made a bicameral agreement not to add new policy riders in the appropriations process unless agreed to by leadership on a bipartisan basis.
Now the only chance that Congress will send the broader provision to President Trump’s desk for 2020 is if negotiators on a bicameral conference committee agree to put the House language in the final package, though there is a chance that the larger chamber could simply approve the bill as passed by the Senate in an effort to avoid a government shutdown that would occur if no spending legislation is signed into law by November 21.
“It’s our hope that the House will insist that today’s minibus appropriations package include the provision to restrict the Department of Justice from interfering with state-legal marijuana programs that passed with bipartisan support,” said Justin Strekal, political director for NORML.
Sen. Bob Menendez (D-NJ) introduced a separate amendment to the large-scale appropriations bill last week that would have called on the attorney general to study the criminal justice implications of marijuana legalization, but the measure was not considered on the Senate floor.
The medical marijuana protections language isn’t the only cannabis-related rider that has advanced via the spending process this year. The Senate Appropriations Committee also approved legislation that includes existing policies barring Washington, D.C. from using its local tax dollars to implement a legal marijuana market, in addition to a provision providing funds to the U.S. Department of Agriculture (USDA) to enact regulations for a legal hemp program.
The latter language is included in the minibus the Senate approved on Thursday, as are report provisions urging the Food and Drug Administration to issue enforcement discretion guidelines for CBD, encouraging the Farm Credit Administration to provide services to hemp businesses and supporting “competitive USDA grants for hemp projects.”
The hemp riders are timely given that USDA unveiled draft rules for hemp, which was federally legalized under the 2018 Farm Bill, on Tuesday. The interim final rule will be formally adopted following a 60-day public comment period.
Another House-passed appropriations bill also includes protections for banks that work with the marijuana industry, and the rider preventing D.C. from establishing a cannabis market was removed from the chamber’s version of the legislation.
While the Republican-controlled Senate is mostly sticking to the agreement not to add new policy riders to appropriations legislation, it could soon take up a separate, standalone marijuana bill: the Secure and Fair Enforcement (SAFE) Banking Act, which would allow banks to service cannabis businesses without being penalized by federal regulators.
The House overwhelmingly approved that legislation in September, along largely bipartisan lines, and the chair of the Senate Banking Committee said recently that he plans to take up the legislation in his panel before the year’s end. He also outlined several changes he’d like to see to the House-passed version in an interview with Marijuana Moment.
Senate Approves Bill Protecting Medical Marijuana States From Federal Intervention was posted on Marijuana Moment.
Original Post: Marijuana Moment: Head Of Nation’s Only Federally Legal Marijuana Farm Develops THC Eye Drops
[Canniseur: Fascinating concept and execution. You need to read this to understand how Dr. ElSohly is going to treat glaucoma with THC. It’s been known for a long time that cannabis can lower eye pressure in glaucoma, but this is the first real application. It’s quite an advancement in the treatment methods for glaucoma.]
The head of the nation’s only federally approved marijuana farm has revealed that he is developing cannabis eye drops to treat glaucoma.
In a podcast interview, pharmacologist Mahmoud ElSohly, director of the University of Mississippi’s Marijuana Research Project, discussed the history of how an eye doctor discovered that cannabis can relieve the interocular pressure associated with glaucoma. But while the THC in the plant treated the symptoms, it also means patients experience the high.
“The best way to treat glaucoma is not to take a drug that will affect your brain, affect your ability to function, the whole rest of your body just to lower the pressure inside the eyes,” ElSohly argued. “The way to do this is to develop, let’s say, eye drops, eye drops from marijuana.”
Both his lab and a separate, unnamed company that licensed the idea are looking into the eye drop possibility, with the company having already begun clinical trials, ElSohly said. It’s a notable advancement because THC is lipophilic, acting like an oil, and so “it doesn’t penetrate into the inner compartments of the eye to lower the pressure.”
“Therefore, only if you take systemically—meaning if you inhale it or swallow it or something—but then you deal with all the side effects of THC,” he said in the interview, which was recorded in February and published this month. “Now we’re developing a pharmaceutical product, and it’s been licensed by the way now, that we take the THC molecule and we modify it in a certain way to allow it to go inside the eye, and once inside, it breaks off and releases THC just in the eye to lower the pressure.”
“You don’t feel any psychological activity, it doesn’t even get into your blood. It’s all localized in the eye,” he said. “We have this product now that is being licensed and being developed as an eye drop.”
“That’s the way to develop pharmaceuticals based on cannabis but not cannabis, based on marijuana but not marijuana,” he added during the appearance on the podcast of anti-legalization organization National Families In Action, for which ElSohly serves as a scientific advisory board member. “That’s the way to do it and develop the medicine.”
The targeted treatment of glaucoma using the novel delivery method that ElSohly described is noteworthy, but it also underscores the potential for the development of other valuable treatment options derived from marijuana that’s being inhibited under prohibition. One barrier that researchers and lawmakers alike have identified is the substandard quality of cannabis produced at ElSohly’s farm.
Currently, the University of Mississippi is the only federally approved source of research-grade marijuana, but scientists have complained about the cannabis supply, which one study found is genetically closer to hemp than products available in state-legal markets. That raises questions about the validity of studies that rely on the government’s marijuana.
The Drug Enforcement Administration said in September that it is taking steps to approve additional marijuana farms beyond ElSohly’s Mississippi operation, three years after the agency initially invited applications for such facilities.
In an earlier podcast segment released in September, ElSohly made a series of remarks that some viewed as reflective of a fundamental misunderstanding of marijuana issues.
The director characterized cannabis containing eight percent THC as “extremely high potency” and expressed confusion as to why individuals would seek out varieties in the commercial market that contain “20 percent or 15 or 18 or any of those high amounts.”
But ElSohly was thinking about marijuana consumption in the context of standardized clinical trials, where individuals would have to consume an entire joint in one sitting in order to compare the effects of a controlled dose with other subjects. Others have pointed out that consumers might prefer higher concentration products because they can achieve the desired effect without having to smoke as much.
Head Of Nation’s Only Federally Legal Marijuana Farm Develops THC Eye Drops was posted on Marijuana Moment.
Original Post: Marijuana Moment: Inventors File Patent Application For Scratch-And-Sniff Marijuana Packages
[Canniseur: Oh boy! Just what we need. Scratch and sniff cannabis packaging. Somehow, this is not a great idea. I don’t believe it’s possible to accurately reproduce the aroma of a good strain of cannabis. The aromas are a complex blend of terpenes, THCs, and other compounds that all contribute to the aroma of a particular strain of cannabis. It’s been tried with wine and it does not work. Why would cannabis be any different?]
Scratch-and-sniff marijuana packaging could be coming to a dispensary near you.
An application for a patent on the cannabis container concept was published by the U.S. Patent and Trademark Office on Thursday. In order to comply with state regulations while at the same time ensuring consumers know what they’re buying, the inventors are pitching a secure package that uses non-THC volatiles to produce the scent of the product when a sticker on the exterior is scratched.
The applicants recognized in their filing that there’s an existing patent application for scratch-and-sniff stickers that are meant to identify the flavor of coffee, but argued their idea is distinct because the other application produced the scent of coffee after it’s brewed whereas this sticker would smell like cannabis in its unsmoked form.
“A major hurdle to the purchase of Cannabis is the secure packaging laws of various states,” the application states. “Packaging can often prevent a purchaser from observing certain characteristics of the Cannabis, such as its scent.”
In a summary of the proposal, the applicants said the “general purpose of the present invention is to provide a Cannabis package and method of selection that includes all the advantages of the secure packaging, and overcomes the drawbacks inherent therein.”
Random Vaughn and Jonathan Tanzer via USPTO.
Another advantage of the proposed packaging is to help patients identify medicinal properties of different marijuana varieties, or assess quality, without having to open the product, the applicants, Random Vaughn and Jonathan Tanzer of Olympia, Washington, argued. They said that scent is is important in “selecting Cannabis for medical reasons such as seizures, headaches, or insomnia.”
The application lists two iterations of the concept. The main one would involve a sticker that would be infused with the scent of cannabis. Terpenes, which are non-intoxicating compounds in the plant that give cannabis its smell and taste, would be used to produce the scent.
For the other, the scent wouldn’t correspond with the actual small of the marijuana itself, but instead various flavor notes, which are sometimes used in cannabis marketing to describe the product’s qualities similar to what’s often done with wine. The applicants listed a diverse list of potential smells, including freshly cut grass, bread, vanilla, bacon, fish and chips, a Christmas tree, cinnamon, after shave, shampoo, the seaside, furniture polish and a Sunday roast.
Inventors File Patent Application For Scratch-And-Sniff Marijuana Packages was posted on Marijuana Moment.